Fig. 6: TNBC with a high allograft rejection score is significantly associated with better survival in the METABRIC and GSE96058 cohorts. | npj Breast Cancer

Fig. 6: TNBC with a high allograft rejection score is significantly associated with better survival in the METABRIC and GSE96058 cohorts.

From: Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer

Fig. 6

Kaplan–Meier plots with log-rank p-values of OS, DFS, and DSS in the METABRIC cohort, and OS in the GSE96058 cohort between low and high allograft rejection in whole, ER+/HER2−, and TNBC cohorts. p-values were calculated by log-rank test. DFS, disease-free survival, DSS disease-specific survival, ER estrogen receptor, HER2 human epidermal growth factor 2, OS overall survival, TNBC triple-negative breast cancer.

Back to article page